Close

PharmAthene (PIP), Altimmune Combination Approved to Trade on Nasdaq Global Under Ticker ALT (ALT)

April 26, 2017 4:48 PM EDT Send to a Friend
As previously announced, PharmAthene, Inc. (NYSE: PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, have signed a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login